Submitted by: Submitted by hexaresrch
Views: 10
Words: 975
Pages: 4
Category: Business and Industry
Date Submitted: 10/22/2015 11:01 PM
Hexa Research Inc.
Industry Research,Custom Research & Consulting
Circulating Tumor Cells Market Analysis, Market Size,
Share, Regional Outlook, Industry Trends, Competitive
Strategies And Segment Forecasts, 2012 To 2020
Industry Insights
Circulating tumor cells (CTC) market is expected to grow over the forecast period owing to the
increasing prevalence of cancer and growing population. The other growth drivers of this market are
introduction of technological advancements such as hybrid method of synthesis of peptides, lifestyle
induced diseases such as obesity & diabetes, sophisticated healthcare infrastructure, increasing
population and awareness. These factors are expected to drive the market over the forecast period.
Cancer is disease caused by abnormal cell growth and has possibility to spread to other parts of the
body too. The symptoms or sign are such as change in bowel movements, unexplained weight loss,
prolonged cough, abnormal bleeding, and new lump. For deciding the procedure of treatment cancer
prognosis plays a vital role. Under liquid biopsy, biomarker is preferred more than other tissue biopsy
procedures, as it follows minimally invasive procedure.
Browse Detail Report With TOC @ http://www.hexaresearch.com/research-report/circulating-tumorcells-industry/
Hexa Research Inc.
Industry Research,Custom Research & Consulting
Globally, this market in 2013 was valued at $ 15 million and over the forecast period it will be growing at
a CAGR of over 27%. By the end of 2020, it is expected that market value will touch the figure of 22
million. Increasing incidences of cancer induced lifestyle habits such as continuous exposure to UV, lack
of exercise, dietary habits, excessive alcohol consumption, smoking and chewing tobacco. Complex
isolation of tumor cells is anticipated to restraining the market over the upcoming five years.
Technology Insights
CTC market is segmented on the basis of technology into tumor cell enrichment & detection, molecular,...